Literature DB >> 32622612

Magnetic resonance imaging assessment of body composition parameters in Crohn's disease.

Ghislain Labarthe1, Michael Dolores1, Mikael Verdalle-Cazes2, Cloé Charpentier3, Pauline Roullee1, Jean-Nicolas Dacher1, Guillaume Savoye3, Céline Savoye-Collet4.   

Abstract

BACKGROUND: Body composition, currently evaluated by computed tomography scan, is related to poor evolution and severity of Crohn's disease (CD). Few MRI studies have been performed, yet it is the most commonly used imaging modality for the surveillance of the disease. AIM: Evaluate the feasibility of MRI body composition measurement and compare the variation according to the activity of the disease.
METHODS: A cohort of 132 consecutive patients was studied. The visceral adiposity index (VAI), subcutaneous adiposity index (SAI) and skeletal muscle index (SMI) were measured. Patients were divided into 2 groups according to disease activity. Sarcopenic status was defined according to the cut off value (SMI < 38.9 cm2/m2 in women and < 54.4 cm2/m2 in men).
RESULTS: MRI measurements of body composition parameters were feasible and reproducible. After adjustment, sarcopenia was more common (2.07 [1.02; 4.27], p = 0.046), and the SMI (-4.90 [-9.36; -0.431], p = 0.032) was lower in active disease. The SAI was lower (-14.7 [-29.8; 0.258], p = 0.054) in active disease. The VAI tended to be higher with active disease (3.91 [-3.50; 11.9], p = 0.34), and the VAI/SAI+VAI ratio was higher (9.40 [4.72; 14.1], p<0.001).
CONCLUSION: Assessment of body composition is feasible and reproducible in routine MR and parameters are related to disease activity.
Copyright © 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Crohn's disease; Magnetic resonance imaging

Mesh:

Year:  2020        PMID: 32622612     DOI: 10.1016/j.dld.2020.06.024

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease.

Authors:  Nik Sheng Ding; Daniel Tassone; Ibrahim Al Bakir; Kyle Wu; Alexander J Thompson; William R Connell; George Malietzis; Phillip Lung; Siddharth Singh; Chang-Ho Ryan Choi; Simon Gabe; John T Jenkins; Ailsa Hart
Journal:  J Crohns Colitis       Date:  2022-09-08       Impact factor: 10.020

2.  Magnetic resonance imaging-based body composition is associated with nutritional and inflammatory status: a longitudinal study in patients with Crohn's disease.

Authors:  Ziling Zhou; Ziman Xiong; Yaqi Shen; Zhen Li; Xuemei Hu; Daoyu Hu
Journal:  Insights Imaging       Date:  2021-12-04

3.  Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study.

Authors:  Sifan Liu; Xueli Ding; Giuseppe Maggiore; Andrea Pietrobattista; Sanjaya K Satapathy; Zibin Tian; Xue Jing
Journal:  Ann Transl Med       Date:  2022-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.